Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Tove, Henriksen"'
Autor:
Nicola Pavese, Jens Christian Hedemann Sørensen, Elena Moro, Andreas Nørgaard Glud, Victor S Hvingelby, Miriam Højholt Terkelsen, Erik L Johnsen, Mette Møller, Erik Hvid Danielsen, Tove Henriksen, Yen Tai, Anne Sofie Møller Andersen, Kaare Meier, Per Borghammer
Publikováno v:
BMJ Neurology Open, Vol 4, Iss 2 (2022)
Introduction Gait difficulties are common in Parkinson’s disease (PD) and cause significant disability. These symptoms are often resistant to treatment. Spinal cord stimulation (SCS) has been found to improve gait, including freezing of gait, in a
Externí odkaz:
https://doaj.org/article/d5cfe35b2e994bab9b8c3404132ffbdd
Publikováno v:
Brain and Behavior, Vol 11, Iss 6, Pp n/a-n/a (2021)
Abstract Objectives Deep brain stimulation, continuous subcutaneous apomorphine infusion, and levodopa–carbidopa intestinal gel infusion, together called device‐aided therapies (DAT), are introduced when oral and transdermal pharmacotherapy are n
Externí odkaz:
https://doaj.org/article/f0b184fee51f47159b0760a969718929
Autor:
Louise M. Jørgensen, Tove Henriksen, Skirmante Mardosiene, Ottilia Wyon, Sune H. Keller, Bo Jespersen, Gitte M. Knudsen, Dea S. Stenbæk
Publikováno v:
Brain Sciences, Vol 12, Iss 5, p 654 (2022)
Patients with Parkinson’s disease (PD) often suffer from non-motor symptoms, which may be caused by serotonergic dysfunction. Deep Brain Stimulation (DBS) in the subthalamic nucleus (STN) may also influence non-motor symptoms. The aim of this study
Externí odkaz:
https://doaj.org/article/2fd0a5a832074a80a20fe74f31a8b467
Autor:
Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek S. Chaudhari, Apeksha B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini
Publikováno v:
Journal of Neurology. 270:2162-2173
Background Caring for a partner or family member with Parkinson’s disease (PD) negatively affects the caregiver’s own physical and emotional well-being, especially those caring for people with advanced PD (APD). This study was designed to examine
Autor:
Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist
Publikováno v:
npj Parkinson's Disease, Vol 4, Iss 1, Pp 1-7 (2018)
Abstract Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices
Externí odkaz:
https://doaj.org/article/fe4c4bf3adf04393a2fc47c77e5e9245
Autor:
Victor S Hvingelby, Miriam Højholt Terkelsen, Erik L Johnsen, Mette Møller, Erik Hvid Danielsen, Tove Henriksen, Andreas Nørgaard Glud, Yen Tai, Anne Sofie Møller Andersen, Kaare Meier, Per Borghammer, Elena Moro, Jens Christian Hedemann Sørensen, Nicola Pavese
Publikováno v:
Hvingelby, V S, Højholt Terkelsen, M, Johnsen, E L, Møller, M, Danielsen, E H, Henriksen, T, Glud, A N, Tai, Y, Møller Andersen, A S, Meier, K, Borghammer, P, Moro, E, Sørensen, J C H & Pavese, N 2022, ' Spinal cord stimulation therapy for patients with Parkinson's disease and gait problems (STEP-PD) : study protocol for an exploratory, double-blind, randomised, placebo-controlled feasibility trial ', BMJ Neurology Open, vol. 4, no. 2, e000333 . https://doi.org/10.1136/bmjno-2022-000333
e000333
e000333
IntroductionGait difficulties are common in Parkinson’s disease (PD) and cause significant disability. These symptoms are often resistant to treatment. Spinal cord stimulation (SCS) has been found to improve gait, including freezing of gait, in a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f64840889e9f2181a2c34ecbd2cc0d0b
https://pure.au.dk/portal/da/publications/spinal-cord-stimulation-therapy-for-patients-with-parkinsons-disease-and-gait-problems-steppd(d857db37-e386-4fcb-b7d8-7d1a2c9f914e).html
https://pure.au.dk/portal/da/publications/spinal-cord-stimulation-therapy-for-patients-with-parkinsons-disease-and-gait-problems-steppd(d857db37-e386-4fcb-b7d8-7d1a2c9f914e).html
Autor:
Tove Henriksen, Olivier Rascol, Regina Katzenschlager, Andrew J. Lees, Guenther Deuschl, Teus van Laar, Claudia Trenkwalder, Donna Lockhart, K. Ray Chaudhuri, Werner Poewe, Harry Staines
Publikováno v:
Parkinsonism & Related Disorders, 83, 79-85. Elsevier
Introduction: The randomized, double-blind phase (DBP) of the TOLEDO study confirmed the efficacy of apomorphine infusion (APO) in reducing OFF time in PD patients with persistent motor fluctuations despite optimized oral/transdermal therapy. Here we
Autor:
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit K. Kukreja, Koray Onuk, Lars Bergmann, James Pike, K. Ray Chaudhuri
Publikováno v:
Antonini, A, Pahwa, R, Odin, P, Henriksen, T, Soileau, M J, Rodriguez-Cruz, R, Isaacson, S H, Merola, A, Lindvall, S, Domingos, J, Alobaidi, A, Jalundhwala, Y J, Kandukuri, P L, Parra, J C, Kukreja, P K, Onuk, K, Bergmann, L, Pike, J & Ray Chaudhuri, K 2022, ' Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries ', Neurology and Therapy, vol. 11, no. 1, pp. 303-318 . https://doi.org/10.1007/s40120-021-00313-9
Standardized and validated criteria to define advanced Parkinson's disease (PD) or identify patient eligibility for device-aided therapy are needed. This study assessed the psychometric properties of clinical indicators of advanced PD and eligibility
Autor:
Harry Staines, Tove Henriksen
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 525, p 525 (2021)
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 525, p 525 (2021)
(1) Background: Subcutaneous apomorphine infusion (SCAI) is one of the three main treatment options for motor fluctuations in advanced Parkinson’s disease (PD). The adherence to SCAI is generally considered to be low due to adverse events and becau
Autor:
Jost, St, Visser-Vandewalle, V, Rizos, A, Loehrer, Pa, Silverdale, M, Evans, J, Samuel, M, Petry-Schmelzer, Jn, Sauerbier, A, Gronostay, A, Barbe, Mt, Fink, Gr, Ashkan, K, Antonini, A, Martinez-Martin, P, Chaudhuri, Kr, Timmermann, L, Dafsari, Hs, EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group, Roongroj, Bhidayasiri, Cristian, Falup-Pecurariu, Beomseok, Jeon, Valentina, Leta, Per, Borghammer, Per, Odin, Anette, Schrag, Alexander, Storch, Mayela Rodriguez Violante, Daniel, Weintraub, Charles, Adler, Paolo, Barone, David, J Brooks, Richard, Brown, Marc, Cantillon, Camille, Carroll, Miguel, Coelho, Tove, Henriksen, Michele, Hu, Peter, Jenner, Milica, Kramberger, Padma, Kumar, Mónica, Kurtis, Simon, Lewis, Irene, Litvan, Kelly, Lyons, Davide, Martino, Mario, Masellis, Hideki, Mochizuki, James, F Morley, Melissa, Nirenberg, Javier, Pagonabarraga, Jalesh, Panicker, Nicola, Pavese, Eero, Pekkonen, Ron, Postuma, Raymond, Rosales, Anthony, Schapira, Tanya, Simuni, Fabrizio, Stocchi, Indu, Subramanian, Michele, Tagliati, Tinazzi, Michele, Jon, Toledo, Yoshio, Tsuboi, Richard, Walker
Publikováno v:
NPJ Parkinson's disease, vol 7, iss 1
Jost, S T, Visser-Vandewalle, V, Rizos, A, Loehrer, P A, Silverdale, M, Evans, J, Samuel, M, Petry-Schmelzer, J N, Sauerbier, A, Gronostay, A, Barbe, M T, Fink, G R, Ashkan, K, Antonini, A, Martinez-Martin, P, Chaudhuri, K R, Timmermann, L, Dafsari, H S & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group 2021, ' Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease ', Parkinson's Disease, vol. 7, no. 1, 48 . https://doi.org/10.1038/s41531-021-00174-x
npj Parkinson's Disease 7(1), 48 (2021). doi:10.1038/s41531-021-00174-x
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
NPJ Parkinson's Disease
Jost, S T, Visser-Vandewalle, V, Rizos, A, Loehrer, P A, Silverdale, M, Evans, J, Samuel, M, Petry-Schmelzer, J N, Sauerbier, A, Gronostay, A, Barbe, M T, Fink, G R, Ashkan, K, Antonini, A, Martinez-Martin, P, Chaudhuri, K R, Timmermann, L, Dafsari, H S & EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group 2021, ' Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease ', Parkinson's Disease, vol. 7, no. 1, 48 . https://doi.org/10.1038/s41531-021-00174-x
npj Parkinson's Disease 7(1), 48 (2021). doi:10.1038/s41531-021-00174-x
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021)
NPJ Parkinson's Disease
Altres ajuts: Projekt DEAL; German Research Foundation (Grant KFO 219). To identify predictors of 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease (PD). In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8d7841aa35f458d7e8179c87f2f859
https://escholarship.org/uc/item/3ns422xh
https://escholarship.org/uc/item/3ns422xh